KOGENATE® FS, ANTIHEMOPHILIC FACTOR (RECOMBINANT), FOR HEMOPHILIA A NOW EASIER FOR PEOPLE TO STORE AT HOME OR ON THE GO
Click for link to article WAYNE, NJ, April 25, 2011 – Bayer HealthCare Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved a new storage option for Kogenate® FS, antihemophilic factor (recombinant), now allowing the product to be stored at room temperature (up to 77° F) for up to one year. [...]
Grifols Press Release: Grifols and Talecris Biotherapeutics Announce the Signing of a Consent Agreement with FTC Staff
Click here for: Grifols FTC Staff Agreement Press Release
BioRx Is Fast 55 Award Finalist
News Release (Cincinnati, Ohio) April 25, 2011 The Cincinnati Business Courier announces that BioRx is again a finalist, for the third consecutive year, in its Fast 55 Award Program. Currently listed in the $50.1 to $199 million category, BioRx also won a Fast 55 Award in 2008 and 2009. The Business Courier moved the 2010 [...]
Novo Nordisk Annals Letter to the Editor
Novo Nordisk Annals Letter to the Editor
Biogen Idec Celebrates World Hemophilia Day
April 15, 2011 Dear members of the bleeding disorders community, On Sunday, alongside individuals with bleeding disorders and their families, advocates and healthcare professionals, Biogen Idec celebrates World Hemophilia Day and reinforces our strong commitment to scientific discovery focused on changing the lives of people with hemophilia. While hemophilia is a new disease area for [...]
Drug That Slows Bleeding Shows Off-Label Dangers
Link to New your Times Article By GINA KOLATA Published: April 18, 2011 A powerful, costly drug approved in 1999 for a small group of patients who may bleed uncontrollably during surgery is now used in a host of other surgical situations, sometimes with serious negative effects, two new studies report. The studies present a [...]
H&P Industries, Inc. Issues a Voluntary Nationwide Recall of All Lots of POVIDINE PREP PADS
Contact: Customer Service 262-538-2900 FOR IMMEDIATE RELEASE — March 15, 2011 —Hartland, Wisconsin, H&P industries, Inc., a manufacturer of over-the-counter products has initiated a voluntary product recall of ALL LOTS of POVIDINE PREP PADS manufactured by H&P Industries, Inc. but which are private labeled for many accounts. This recall has been initiated due to results of the [...]
Grifols Alphanate vCJD Labeling Press Release
FOR IMMEDIATE RELEASE FDA Approves Revised Alphanate® Labeling to Include Reduced Infectivity of an Experimental Model Agent for vCJD Alphanate® is the first plasma-derived blood clotting factor to include labeling statements on manufacturing processes that provide a reasonable assurance of removal for low levels of a variant Creutzfeldt-Jakob disease (vCJD) model agent. Barcelona, Spain (March [...]
CSL Behring Receives FDA Approval of Corifact™ for Treatment of Congenital Factor XIII Deficiency
View Press Release
Bayer Hemophilia Leadership Development Program
Apply for the Bayer Hemophilia Leadership Development Program today. It’s your chance to participate in a summer internship that will help develop the skills needed to be a successful leader. Take this opportunity to ask questions, learn from business professionals, develop key relationships, prepare for real-world transitions after college, and more importantly, have FUN! Deadline [...]
Assisting and Advocating for the Bleeding Disorders Community
